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Abstact 9 
 10 
Context 11 
Gene guns have been used to deliver deoxyribonucleic acid (DNA) loaded micro-particle and 12 
breach the muscle tissue to target cells of interest to achieve gene transfection.  13 
Objective 14 
This paper aims to discuss the potential of microneedle (MN) assisted micro-particle delivery 15 
from gene guns, with a view to reducing tissue damage. 16 
Method 17 
Using a range of sources, the main gene guns for micro-particle delivery are reviewed along 18 
with the primary features of their technology, e.g., their design configurations, the material 19 
selection of the micro-particle, the driving gas type and pressure. Depending on the gene gun 20 
system, the achieved penetration depths in the skin are discussed as a function of the gas 21 
pressure, the type of the gene gun system, and particle size, velocity and density. The concept 22 
of MN-assisted micro-particles delivery which consists of three stages (namely, acceleration, 23 
separation and decoration stage) is discussed. In this method, solid MNs are inserted into the 24 
skin to penetrate the epidermis/dermis layer and create holes for particle injection. Several 25 
designs of MN array are discussed and the insertion mechanism is explored, as it determines 26 
the feasibility of the MN based system for particle transfer. 27 
Results 28 
The review suggests that one of the problems of gene guns is that they need high operating 29 
pressures, which may result in direct or indirect tissue/cells damage. MNs seem to be a 30 
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promising method which if combined with the gene guns may reduce the operating pressures 31 
for these devices and reduce tissue/cell damages. 32 
Conclusions 33 
There is sufficient potential for MN-assisted particle develivery systems.  34 
 35 
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1. Introduction 38 
A gene gun, involving “particle bombardment” or “biolistic delivery” is a particle accelerator, 39 
which can deliver deoxyribonucleic acid (DNA) loaded micro-particles at sufficiently high 40 
velocities to breach the surface of target tissue and to penetrate to a depth to achieve gene 41 
transfection in the cells. A gene gun is considered to be a unique concept which was first used 42 
to deliver genetic materials into plant cells (Klein et al., 1987; Klein et al., 1992; Sanford et al., 43 
1993; Svarovsky, 2008; Huang et al., 2011; O'Brien et al., 2011; Manjila et al., 2013). The 44 
technique has been used to transfer DNA-coated micro-particles to achieve gene transfection 45 
into many types of cells and organs (e.g., Meacham et al., 2013; Bennett et al., 1999), for 46 
example, mammals (Cao et al., 2013; Ettinger et al., 2012; Da’dara et al., 2002; Kuriyama et 47 
al., 2000; Sakai et al., 2000; Williams et al., 1991), plants (Kuriakose et al., 2012; Zuraida et 48 
al., 2010; Klein et al., 1992), artificially cultured cells (O’Brien and Lummis, 2011, 2006), fungi 49 
(Gu et al., 2011; Armaleo et al., 1990) and bacteria (Nagata et al., 2010; Smith et al., 1992). A 50 
number of commercial gene guns have been manufactured and used for in vivo gene 51 
transfection in plants, living animals, cultured cells, e.g., the PowderJect system developed 52 
originally by the University of Oxford (UK) (Bellhouse et al., 2006), the Helios gene gun by 53 
Bio-rad, Hercules, CA (USA) (Belyantseva, 2009), and the SJ-500 portable gene gun by 54 
Biotech instrument, New Jersey (USA). The Helios and portable gene guns are shown in 55 
Figure 1. In a research context, Da’dara et al. (2002) have used a Helios gene gun to delivery 56 
Sm23-pcDNA (an integral membrane protein) to mice to evaluate the immunogenicity of the 57 
protective efficacy of the DNA vaccination. Ahlen et al. (2013) have used a Helios gene gun to 58 
explore a method for monitoring hepatitis B and C viruses (HBV/HCV) specific to immune 59 
responses in mouse. 60 
 61 
4 
 
Loading the micro-particles with DNA (for example onto gold particles) is an important step in 62 
using this technology, as discussed by Zhao et al. (2012); O’Brien and Lummis (2006, 2011), 63 
Rao (2010), Satish, (2009), Svarovsky et al. (2008), and Thomas et al. (2001). However, a 64 
detailed discussion on these issues is outside the scope of this paper.  65 
 66 
Such guns have been proposed for gene delivery in the treatment of some of the major 67 
diseases such as cancer (Nguyen-Hoai et al., 2012; Aravindaram et al., 2009; Han et al., 2002; 68 
Chen et al., 2002); these researchers have fired gene loaded micro-particles into mammalians 69 
or cultured cells instead of humans to study gene expression and cell damage. For example, 70 
Yoshida et al. (1997) used a gene gun to deliver DNA coated Au micro-particles into the liver 71 
of living rat at 250 psi (~17.2 bar) pressure, which resulted in a good gene expression but 72 
caused a number of cell deaths. The work also showed that cell damage was not obtained 73 
below 150 psi of pressure. Sato et al. (2000) have used various types of gene guns to transfer 74 
genes into live rodent brain tissue, which confirmed gene expression, but with mechanical 75 
damage to cells. Uchida et al. (2009) have fired plasmid DNA into cultured mammalian cells 76 
(e.g., human embryonic kidney (HEK293) cell, human breast adenocarcinoma (MCF7) cell) 77 
using a gene gun, which showed that transfection is achieved in the cells, but the cell damage 78 
occurs at operating pressures greater than 200 psi (~13.8 bar). O’Brien and Lummis (2011) 79 
have cultured HEK293 cells as a target for the biolistic transfection using a gene gun. Their 80 
work showed that nano-particles gave a similar performance to micro-particles for biolistic 81 
transfection, but created less cell damage.  82 
 83 
The above works show that cell damage may be a problem for biolistic micro-particle delivery, 84 
due to significant gas and particle impactions on the tissue. This also means that while gene 85 
guns have been reported to be successful in many instances, they may have some 86 
disadvantages. Generally, for most gene gun systems, the maximum penetration of the 87 
micro-particle can breach the stratum corneum and end inside the epidermis layer of the tissue 88 
(Yager et al., 2013; Liu, 2006; Quinlan et al., 2001; Bennett et al., 1999). The epidermis layer 89 
is normally considered to be a target site for gene delivery due to its accessibility (Soliman et 90 
al., 2011b; Liu, 2006; Quinlan et al., 2001; Trainer and Alexander, 1997). However, a high 91 
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pressure is required for most gene guns, which might damage the tissue after the impaction of 92 
the pressurized gas on the skin.  93 
 94 
Figure 1: Left: The commercial hand-held gene gun of SJ-500 (Biopex, 2012), Right: the 95 
commercial Helios gene gun (Bio-rad, 2012) 96 
Cell damage can be reduced by decreasing the particle size and/or operating pressure, as 97 
both reduce the impact forces. In order to satisfy these conditions and, possibly, increase the 98 
penetration depth of the micro-particle in the target, an innovative concept of combining MNs 99 
with a particle delivery system, namely MN-assisted micro-particle delivery, has been 100 
proposed recently by Zhang et al. (2013). The MNs are discussed in section 3 of this paper. 101 
The operating principle of the delivery in the approach of Zhang et al. (2013) is that a pellet of 102 
micro-particles is loaded on a ground slide which is accelerated by a pressurized gas to a 103 
sufficient velocity. The pellet is released after the ground slide reaches the end of a barrel in 104 
the system, and separates into micro-particles of a narrow size distribution by impaction on an 105 
open mesh; these separated micro-particles then penetrate into the desired target. The 106 
resistance of the target/skin to the penetration of the micro-particles is reduced by using MN to 107 
create a number of holes through which the micro-particles can enter, without the need for 108 
very high gas pressures.  109 
 110 
MN assisted micro-particle delivery seems to be a promising approach for dry particulate 111 
delivery, but the potential of this method needs to be discussed thoroughly as it is still at an 112 
early stage of development. To this end, the main types of gene gun systems for micro-particle 113 
delivery and their operating principles are reviewed. The micro-particle material and size for 114 
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these gene guns are discussed, and the range of gas pressures and particle velocities are 115 
considered.  116 
 117 
In this paper, MN arrays are discussed to understand how various geometries affect 118 
penetration of the target material and formation of holes, which remain after the needles are 119 
removed. This discussion provides relevant background knowledge and a sound foundation 120 
for further improvement of gene gun systems, with the help of MN assisted micro-particle 121 
delivery to achieve similar levels of penetration depth, but with less cell damage. To further 122 
understand the advantage of MN assisted micro-particle delivery, a comparison with other 123 
physical cell targeting approaches is discussed. Finally, some simplified models of the 124 
micro-particle delivery in the skin are described, which will be useful in predicting the 125 
penetration depths achieved by MN assisted gene gun delivery. 126 
 127 
2. Main gene guns 128 
2.1 Configurations and operating conditions 129 
Based on the principles of the operation process and driving forces, we define that the gene 130 
guns can be divided into three types, namely:  powder gene gun, high-voltage electric gene 131 
gun and gas gene gun.  132 
 133 
A powder gene gun is the original device which uses an ignition gunpowder as a driving force 134 
to promote the movement of bullets of macro-projectiles, thus accelerating the micro-particles 135 
which are loaded onto the bullet (Huang et al., 2011; O’Brien and Lummis, 2007; Zhou, 1995; 136 
Klein et al., 1987; Sanford et al., 1987). An electric gene gun uses a high voltage (HV) to 137 
vaporize water droplets; the expanding gas is used to achieve the acceleration of 138 
micro-particles (Christou et al., 1990). A gas gene gun releases a high pressure gas to 139 
accelerate the micro-particles (or micro-particles loaded ground slide) to a sufficient velocity to 140 
breach the barrier of the target (Zhang et al., 2013; Soliman et al., 2011b; Liu, 2007; Kendall et 141 
al., 2002; Zhou, 2000). 142 
 143 
Powder gene guns were originally developed to deliver genetic material coated micro-particles 144 
into plant cells (Klein et al., 1987; Klein et al., 1992; Svarovsky, 2008; O'Brien et al., 2011; 145 
Manjila et al., 2013). As shown in Figure 2, an explosion of gun powder accelerates 146 
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DNA-coated micro-particles attached onto the front surface of o macro projectile. Klein et al. 147 
used tungsten micro-particles of 4 μm average diameter, which could be accelerated to 400 148 
m/s. However, the explosion of the gun powder is noisy and may cause cell/tissue damage.  149 
 150 
Figure 2:  A schematic sketch of the powder gun (redrawn from Klein et al. (1987)) 151 
Zhou (1995) improved the design of Klein et al. (1987) and patented a powder gun (Figure 3) 152 
which is composed of a gun body, a gun barrel, a ground slide, a baffle plate and a baffle plate 153 
fixed pipe. An ignition of gunpowder, caused the bullet to accelerate and hit a ground slide, 154 
which then impacts on a baffle plate. Thus, the micro-particles gain an initial velocity to leave 155 
the ground slide, pass through the central hole of the baffle plate and penetrate into the tissue. 156 
The advantage of this powder gene gun is that the use of ground slide can reduce explosion 157 
damage to tissue. The base is designed as a shock absorber to reduce the recoil force, using 158 
a spring attached to the firing pin. 159 
160 
Figure 3: The layout of powder gene gun (redrawn from Zhou (1995)) 161 
Christou et al. (1990) have used a type of electronic gene gun to deliver DNA-coated gold 162 
micro-particles into soybean seeds; a schematic sketch of the high-voltage electric gene gun is 163 
shown in Figure 4. Yang et al. (1990) have applied an electronic gene gun to transfer genes 164 
Blank Charge  Micro-particles  
Firing pin 
Gun barrel 
Nylon macro-projectile Vents Target 
Baffle Plate 
Powder  Screw  Firing pin Gun barrel 
Spring Bullet Gas outlet hole Ground slide 
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into the muscle, tissue and liver of a mouse, using 1-3 μm diameter golden particles. The 165 
disadvantage of their gun is that a high voltage up to 18 kV is required to deliver a 166 
micro-particle penetration depth of 125 μm. Recently, Ikemoto et al. (2012) used a type of 167 
high-voltage electric gene gun, namely, an electrospray device to accelerate liquid droplets in 168 
a high voltage (12 kV) to collide with DNA coated micro-particles and deliver them into living 169 
cells. 170 
 171 
Gas gene guns can be classified into two different delivery methods. The first uses a high 172 
pressure gas to push the micro-particle coated ground slide to achieve the goal of particle 173 
acceleration. The disadvantage is that a very high operating pressure is required to achieve 174 
the desired micro-particle impact velocity. However, the advantage is that the ground slide 175 
prevents the released gas from impacting on tissue. The second method mainly uses a high 176 
pressure gas (e.g., N2, He) to directly push the DNA-coated micro-particles to a sufficient 177 
velocity to breach the stratum corneum, penetrate into the epidermis/dermis layer of the skin or 178 
deeper tissues. The disadvantage is that very high gas pressure may damage the tissue and 179 
the muscles. The advantage is that the micro-particle can reach a desired velocity under lower 180 
operation pressure as the micro-particles have very small mass.  181 
 182 
Figure 4: The schematic sketch of the high-voltage electric gene gun (redrawn from Christou et 183 
al. (1990)) 184 
Using the principles of the first delivery method, Zhou (2000) has invented a kind of 185 
high-pressure gene gun which consists of a casing, the compressed gas inlet pipe, emitting 186 
cavity and bombarding cavity. The schematic diagram of this gun is shown in Figure 5 which 187 
shows both the states of the gun before and after operation. The emitting cavity consists of an 188 
air storage house, membrane, bullet, baffle plate and sample holder. The membrane will be 189 
HV (-) 
Water drop let Micro-particles  
HV (+) 
Stopping screen 
Target 
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ruptured when the air storage house reaches a certain pressure. High pressure gas is able to 190 
accelerate the bullet to the baffle plate. Since the bullet is blocked by the baffle plate, the 191 
coated particles will leave the surface of the bullet, go through the centre hole of the baffle 192 
plate and launch into the sample, thus completing the gene injection. In addition, the gas will 193 
be released from the vent hole. It has been claimed that this instrument has good stability, high 194 
efficiency, does not produce impurities, and particles can also attain a higher initial speed. 195 
However, it is generally applied for plant tissues. 196 
 197 
Mitchell et al. (2003) have conducted many experimental and numerical studies on the light 198 
gas gun (LGG), as shown schematically in Figure 6. The LGG uses a high pressure helium 199 
gas to drive the micro-particle coated ground slide to a certain velocity. In this case, the 200 
polystyrene particles of 99 μm diameter have been used and the impact velocities of the 201 
particles have been shown to reach 170, 250 and 330 m/s under 20, 40 and 60 bar operation 202 
pressures. 203 
 204 
Figure 5: The schematic diagram and principle of high-pressure gas gene gun (redrawn from 205 
Zhou (2000)) 206 
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207 
Figure 6: The schematic sketch of light gas gun (redrawn from Mitchell et al. (2003)) 208 
 209 
Williams et al. (1991) have studied a helium-driven gene gun which is somewhat similar to the 210 
design of Zhou’s (2000), as shown in Figure 7. In this case, a membrane in the system breaks 211 
after the gas pressure reaches a certain value. The micro-projectiles are accelerated by the 212 
helium gas and separated well by a stopping screen. In addition, the large particle is blocked 213 
by a screen to avoid tissue damage. In this case, golden particles of 1 - 3 μm and 2 - 5 μm 214 
diameters have been fired and penetration depths of 150 μm and 200 μm have been obtained 215 
in a mouse liver, under 1300 psi operating pressure. 216 
 217 
Figure 7: The schematic sketch of helium-driven gene gun (redrawn from Williams et al. 218 
(1991)) 219 
 220 
Kendall (2002) has reported a contoured shock tube which is shown in Figure 8. In this case, 221 
the compressed gas will pressurize the membrane, and the micro-particle will be accelerated 222 
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by a shock wave as the gas pressure rises to the point where the membrane ruptures. Liu et 223 
al. (2004a) and Liu (2006) have described an injection device, namely PowderJect (Figure 9), 224 
which uses helium gas as the source of momentum. A trigger actuates a mechanism to 225 
release helium gas, which expanded to accelerate the micro-particles to a sufficient 226 
momentum to pierce the outer layer of the target and into the cells of interest.  227 
 228 
Figure 8: The schematic diagram of contoured shock tube (redrawn from Kendall (2002)) 229 
 230 
Figure 9: A schematic diagram of the PowderJect system (redrawn from Liu (2006)) 231 
 232 
Zhang et al. (2007) have introduced the principle of the Helios gene gun which contains 233 
acceleration, separation and deceleration stages. The process of micro-particle delivery is 234 
shown in Figure 10. This gene gun uses helium gas to accelerate DNA-coated micro-carriers 235 
which are separated by a stopping screen. The separated micro-particles exit from the gene 236 
gun at high speed, penetrate the tissue to the targeting area, enter into the cell and hit the 237 
nucleus membrane.  238 
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 239 
Figure 10: Gene transfer stages of the biolistic gene gun (redrawn from Zhang et al. (2007)); La, 240 
Ls and Ld are the distance of acceleration, separation and deceleration stages. 241 
 242 
In addition, Zhou (2007) has created a special liquid gene sprayer (Figure 11) which is 243 
different from the above three gene gun types. It has been used to deliver liquid-form 244 
medication into the human body and consists of an interconnected casing and magazine. The 245 
magazine comprises of a hollow cylinder and sliding piston rod set; emission holes are 246 
arranged at the front end of the cylinder and the front end of the casing is fixed to rear end 247 
opening. An energy-storage driving mechanism consists of a spring and impeller and set in the 248 
internal cavity of the casing. The impeller moves backward to press the spring to store the 249 
energy, and pushes forward by a driving force from the released spring. This device uses a 250 
small volume energy storage device to inject the required amount of biological gene, and does 251 
not need any separate air supply equipment; it is easy to handle and carry. It uses the liquid as 252 
the DNA particle’s carrier and hence golden particles are not required in this device. The DNA 253 
particles will be suspended in the liquid. Before using this device, the head of the hollow 254 
cylinder is inserted into the DNA particle coated liquid, and the sliding piston rod is pulled out 255 
to extract the liquid and load the gun. Then the spring is compressed very tightly, storing 256 
energy (see Figure 11a), which is released to accelerate the impeller and sliding piston rod; 257 
then the DNA particle coated with liquid are pushed out from the emission hole and penetrate 258 
into the tissue of plant or human to the target cells of interest. The state of the liquid gene gun 259 
after injection is shown in Figure 11b. 260 
Targeting 
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Deceleration 
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Acceleration 
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La 
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Source 
Helium 
Skin Body DNA-coated 
micro-carriers 
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 261 
Figure 11: The liquid gene sprayer: A: The liquid gene gun at energy storage state, B: The 262 
state of liquid gene gun after injection (redrawn from Zhou (2007)) 263 
 264 
Figure 12: The schematic of the laser plasma jet (redrawn from Menezes et al. (2012)) 265 
 266 
Recently, Menezes et al. (2012) have designed an advanced laser plasma jet (see Figure 12) 267 
to deliver DNA-coated micro-particle. The operating principle is that a laser beam is fired and 268 
ablates a thin aluminum foil, using lenses for focusing. The laser ablation is confined by the 269 
BK7 glass overlay to improve performance. Thus, it causes the foil to evaporate into an ionized 270 
vapor and the sudden blow-off causes a shock wave to breach the foil to accelerate DNA 271 
Spring  Stem Impeller Trigger  Magazine  Baffle  Sliding piston 
a  
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coated micro-particles. The device provides micro-particles impact velocities of up to 1100 m/s, 272 
which is faster than other gen guns (e.g. CST, LLG). However, this technique is costly due to 273 
the use of laser ablation.  274 
 275 
2.2 Micro-particle materials and size 276 
The materials and size of the micro-particles which are used in gene guns have significant 277 
importance on the operation of the system, e.g. by determining the routes and extent of 278 
particle penetration into tissue. In general, the routes of the micro-particle penetration in the 279 
tissue are normally divided into two types, which are the extracellular and intercellular routes 280 
(Bryan et al., 2013; Soliman, 2011; Mitchell et al., 2003). As presented in Figure 13(a-b), the 281 
penetration routes of the micro-particles in tissue depend on the particle size. The extracellular 282 
route is followed for large particle delivery, e.g., for epidermal powder immunization (Soliman, 283 
2011; Hardy et al., 2005). An illustration of the range of particle material and sizes for the 284 
relevant gene gun systems is listed in Table 1. It shows that the extracellular route is normally 285 
followed for the less dense materials (e.g., stainless steel, polystyrene and glass) with 286 
diameters ranging from 15 to 99 μm. Hardy et al. (2005) have reported that particle diameters 287 
ranging from 25 to 100 μm are expected to follow the extracellular route, as their momentum is 288 
insufficient to breach the target barrier of target, due to the combination of relatively low 289 
density and small size. It has been recommended that stainless steel or polymer 290 
micro-particles should be used for extracellular routes, due to their biocompatibility and low 291 
cost (Soliman, 2011; Sung et al., 2011; Singh and Dahotre, 2007; Binyamin et al., 2006; Disegi 292 
et al., 2000).  293 
  294 
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 295 
Figure 13: Schematic diagram of the extracellular and intercellular failure mechanisms (a): 296 
extracellular failure mechanism for large particles (b): intercellular failure mechanism for small 297 
particles (redrawn from Mitchell et al. (2003)). 298 
 299 
In contrast, the intercellular route (e.g. for DNA immunization), uses smaller size, but much 300 
more dense gold or tungsten micro-particles (Soliman, 2011; Mitchell et al., 2003). In order to 301 
deliver DNA into cells effectively, dense materials are preferred which are prepared into 302 
micro-particles of diameters ranging from 0.6 to 6 μm (Soliman, 2011; Rao, 2010; Hardy et al., 303 
2005) which are also smaller than the cell diameters. High-speed micro-particles breach the 304 
skin and may penetrate through the individual cell membranes. It is well known that the most 305 
recommended material of these micro-particles for gene gun system is gold due to its high 306 
density, low toxicity and lack of chemical reactivity (Valenstein, 2012; Rosi et al., 2006; 307 
Macklin, 2000). However, tungsten micro-particles have also been used as micro carriers in 308 
gene gun systems, due to their lower cost. Tungsten particles have some disadvantages for 309 
genetic transformation, such as non-biocompatibility and toxicity (Bastian et al., 2009; 310 
Yoshimisu et al., 2009; Russell et al., 1992). Recently, Hou et al. (2013) have used titanium 311 
dioxide (TiO2) for biolistic micro-particle delivery due to their biocompatibility (Singh and 312 
Dahotre, 2007) and low density (2 g/cm3) which may reduce the cell damage after particle 313 
impaction. The particle impaction may cause cell damage (O’Brien and Lummis, 2011; Sato et 314 
al., 2000), which is a significant area for gene gun research. 315 
 316 
2.3 Gas pressure and particle velocity 317 
Up to now, gene gun systems have been widely used to deliver DNA loaded micro-particles 318 
into cells for research of DNA transfection, e.g., CST (Rasel et al., 2013; Liu, 2008; Truong et 319 
(a) 
Impact Direction 
(b) 
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al., 2006; Liu et al., 2006; Kendall, 2002) and Helios gene gun (O’Brien and Lummis, 2011; 320 
Belyantseva, 2009). Helium and compressed air gases are often used as driving forces to 321 
accelerate micro-particles for gene gun system. Especially, helium gas is recommended for 322 
most gene gun systems due to its non-toxic, low density, lack of chemical inactivity and high 323 
compressibility factor (Marrion et al., 2005), which allow the particles to reach higher velocities 324 
(Tekeuchi et al., 1992). Compressed air is often used as a substitute for helium due to its lower 325 
cost. 326 
 327 
The gas pressure is a major factor which should be considered for gas gene gun systems. It 328 
directly affects the velocity of the micro-particles, e.g., Liu et al. (2008) demonstrated that 1.8 329 
μm diameter gold micro-particles can reach a velocity of 580, 650, 685 and 710 at 3, 4, 5 and 6 330 
MPa, respectively. In addition, the velocity is also related to the micro-particle size and density:  331 
particle velocity is increased from an increase in operating pressure and a decrease in particle 332 
size.  333 
17 
 
Table 1: Illustration of the particle material and size for the relevant gene gun systems  334 
Type of gene gun Material of 
particles 
Average diameter of 
micro-particles (μm) 
Reference 
Powder particle gun (PPG) Tungsten 4 Klein et al. (1987) 
Helium-driven apparatus (HDA) Tungsten 3.9 Williams et al. (1991) 
Gold 1-3, 3-5  
Conical nozzle (CN) Polymeric  4.7, 15.5 and 26.1 Quinlan et al. (2001) 
Converging-diverging nozzle 
(CDN) 
Polystyrene 4.7  Kendall et al. (2004a) 
Pneumatic gun (PG) 
 
Gold 0.47 ± 0.15, 1.1 ± 0.1 
    
Rinberg et al. (2005) 
Silicon 2 – 18 Zilony et al. (2013) 
Gold 1.6 
Light gas gun (LGG) Stainless steel 25 Mitchell et al. (2003) 
Contoured shock tube 
(CST)/LGG 
Polystyrene 15.5, 25.2, 48 and 99 
CST 
 
Gold 3.03 Truong et al. (2006) 
Polystyrene 15 and 48 
Glass 46 
Gold 2.7 and 3.5 
Polystyrene 39 ± 1 Liu et al. (2006) 
Helios gene gun 
 
 
Gold 
 
 
0.6, 1.0 and 1.6 Uchida et al. (2009) 
1 
 
O’Brien and Lummis 
(2011); Kuriakose et al. 
(2012); 
Cao et al. (2013) 
Biolistic PDS/1000 Helium 
system (BioRad, USA) 
Gold 0.6, 1.0 and 1.6 Zuraida et al. (2010) 
BioWare low pressure gene 
gun 
Gold 1 Yen and Lai (2013) 
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Along with the development of gene gun technology, the achievable particle velocity and 335 
penetration depth in the target vary between gene gun systems. For example, Quinlan et al. 336 
(2001) have applied a conical nozzle to accelerate polymeric micro-particles of 4.7, 15.5 and 337 
26.1 μm diameters, to reach velocities of 350, 460 and 465 m/s at 60 bar pressure, 338 
respectively. A contoured nozzle has been tested by Quinlan et al. (2001) who employed 60 339 
bar to accelerate polymeric micro-particles of 4.7 μm diameter to a velocities of about 1000 340 
m/s, but 26.1 μm diameter of particles only reached 740 to 810 m/s. The velocity of polymeric 341 
micro-particles of 15.5 μm diameter only reaches 330 m/s at 60 bar for the LGG system 342 
(Mitchell et al., 2003). Kis et al. (2011) have concluded that the particle velocity reached about 343 
700 m/s for CST (Liu et al., 2006) and range from 200 to 800 m/s for converging-diverging 344 
nozzles (Liu et al., 2004b; Kendall, 2002; Quinlan et al., 2001). Recently, Menezes et al. (2012) 345 
have operated an advanced laser plasma jet to drive gold micro-particles of 1 μm diameter to 346 
achieve an average velocity of 1100 m/s within a distance of only 10 mm. The particular 347 
achievements (e.g., particle velocity, operating pressure and penetration depth) for various 348 
gene gun systems are listed in Table 2. 349 
 350 
From the above studies, it can be concluded that the operating pressures for gene gun 351 
systems generally vary from 20 to 60 bars. Xia et al. (2011) have suggested that the pressure 352 
should be held below about 13 bar to minimise damage from the impaction of pressurized gas 353 
on soft tissue. Uchida et al. (2009) achieved gene transfection is cells but noted damage if the 354 
operating pressure is over 13 bar. These reports demonstrate that cell death is unavoidable for 355 
many of the current generation of gene gun systems. Mitchell et al. (2003) show that golden 356 
micro-particles of 3.03 μm diameter employed at 60 bar pressure in the CST only reach a 357 
maximum penetration depth of 60 μm in the canine buccal mucosa. Normally, the viable 358 
epidermis layer of skin is the target area for gene gun systems. Mitchell et al.’s (2003) results 359 
show that micro-particles require a still higher velocity to penetrate through the stratum 360 
corneum, which means higher operating pressures are necessary. However, Mitchell et al. 361 
(2003) also show stainless steel micro-particles of 25 μm diameter can achieve 124 μm 362 
penetration depths in the canine buccal mucosa at 20 bar pressure (see Table 2). But O’Brien 363 
and Lummis (2011) show that cultured cells are damaged by gold micro-particle of 1 μm 364 
diameter, when operating at 3.4 bar pressure using a Helios gene gun. They indicate that 365 
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stainless steel micro-particles of 25 μm diameter impact on the tissue at a velocity of 170 m/s 366 
will damage the target tissue and cells. Thus, a new concept of applying MN to micro-particle 367 
delivery, which may reduce the cell damage, is discussed in section 4.2. 368 
 369 
Table 2: Illustration of the materials and size of micro-particles used in gene gun systems  370 
Gene 
gun 
Material and 
average diameter 
of micro-particles  
Operating 
pressure 
(bar) 
Velocity 
at impact 
(m/s) 
Target and 
maximum 
Penetration 
depth in target  
Reference 
PPG Tungsten,  4 μm  N/A 430 Onion, 40 μm Klein et al. (1987) 
HAD Gold, 1 - 3 μm 90 N/A Mouse liver 
tissue, ~ 130 μm 
Williams et al. 
(1991) 
CN Polymers, 4.7, 15.5 
and 26.1 μm  
60 350, 460 
and 465 
N/A Quinlan et al. 
(2001) 
LGG Stainless steel, 25 
μm  
20 170 Canine buccal 
mucosa, 124 μm 
Mitchell et al. 
(2003) 
CST Gold, 3.03 μm  60 550 Canine buccal 
mucosa, 60 μm 
CST Gold, 1 ± 0.2 μm  40 580 Human skin, 66 
μm 
Kendall (2002) 
CST Polystyrene,  39 
μm  
60 570 ± 
14.7 
N/A Liu et al. (2006) 
Helios 
Gene 
Gun 
Gold,  40 nm and 
1 μm  
5  N/A Mouse ear 
tissue, 50 ± 11 
μm and 31 ± 6 
μm 
O’Brien and 
Lummis (2011) 
Laser 
plasma 
jet 
Gold, 1 μm; 
Tungsten, 1 μm 
N/A 1100 N/A Menezes et al. 
(2012) 
 371 
  372 
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3. MNs 373 
3.1 Types and configurations of MNs 374 
Henry et al. (1998) are widely regarded as the first to have developed a method of transdermal 375 
drug delivery using MNs, which has gradually developed for various applications of drug 376 
delivery. MN arrays are minimally invasive device that bypass the outer layer of skin, namely 377 
the stratum corneum, to achieve enhanced transdermal drug delivery (Olatunji et al., 2013; 378 
Donnelly et al., 2012; Prausnitz and Langer, 2008). MN are normally separated into two 379 
categories, namely, solid and hollow (Koelmans et al., 2013; Han et al., 2008; Qi et al., 2007). 380 
Each of these can be made of different materials and used for various functionalities, 381 
depending on their designs. The most common materials used for fabricating MN are metal, 382 
silicon, and polymer (Kim et al., 2012; Memon et al., 2011; Zhao et al., 2006). The primary 383 
metals used for MNs are stainless steel (Kim et al., 2012; Quan et al., 2010; Bal et al., 2008; 384 
Martanto et al., 2004) and titanium (Kim et al., 2010; Fermandez et al., 2009; Parker et al., 385 
2007). Metal MNs have the advantages of low cost, tougher hardness, ease of penetration into 386 
the tissue and they are not easily broken in the tissue. Silicon and silica materials have better 387 
biocompatibility than metallic materials, but they are expensive (Chen et al., 2013, 2008). 388 
Furthermore, they break up more easily and fragments may be left inside the tissue after MN 389 
removal (Memon et al., 2011; Zhao et al., 2006). However, silicon is the first material used to 390 
fabricate MNs for pre-treatment of skin prior to patch application, e.g., Henry et al. (1998) have 391 
used solid conical silicon MNs (Figure 14a) with a height of 0.15 mm, inner diameter of 80 μm 392 
and tip diameter of 1 μm to increase skin permeability and to provide an effective delivery of 393 
drugs to diffuse through the skin. Mikszta et al. (2002) used a silicon MN array (see Figure 394 
14b) for gene delivery in skin.  395 
 396 
Polymeric materials are a cheap option which can exhibit biocompatibility and biodegradability, 397 
but the hardness is generally lower (Nayak and Das, 2013; Oh et al., 2008; Han et al., 2007; 398 
Park et al., 2005). Various types of polymer have been used for fabricating MNs, such as 399 
poly-glycolic acid (PGA) (Park et al., 2006, 2005) and polycarbonate (PC) (Han et al., 2007). 400 
Park et al. (2005) have fabricated a PGA solid MN array with needle length of 1500 μm, base 401 
diameter of 200 μm tapering to tip diameter of 20 μm. An example of solid polymer MN array is 402 
shown in Figure 15a. Recently, Donnelly et al. (2011) have used poly (vinyl) alcohol (PVA) to 403 
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fabricate solid MN arrays with a needle height of 600 μm, base width of 300 μm, and MN 404 
interspacing of 300 μm. As can be seen from Figure 15 (b), MNs have been fabricated into 405 
uniform conical-shaped needles.  406 
 407 
 408 
Figure 14: (a). Solid conical MN arrays (Henry et al., 1998) (b) Silicon MN array used for gene 409 
delivery in skin (Mikszta et al., 2002). 410 
 411 
(a)  412 
(b)  413 
Figure 15: (a): Solid MN array made with the help of PGA (Park et al., 2005) (b): Solid MN 414 
array made with the help of PVA (Donnelly et al., 2011) 415 
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 416 
Hollow MN arrays are normally used for fluid infusion of liquid drug and nanoparticles into the 417 
skin (Han et al., 2008). However, they are not widely used due to their cost and complex 418 
fabrication methods (Zhu et al., 2012). An example of the hollow MN array designed by 419 
Stoeber and Liepmann (2000) is shown in Figure 16a. It is a hollow conical MN array with a 420 
height of 200 μm and a channel diameter of 40 μm. McAllister et al. (2000) have improved 421 
Henry et al.’s (1998) design, by inserting a hole in the centre of each MN to fabricate a hollow 422 
silicon MN array.  423 
 424 
 425 
Figure 16: (a) Hollow conical MN arrays on the right (Stoeber and Liepmann, 2000) (b) hollow 426 
silicon MN array with sloping side walls (Gardenier et al., 2003) 427 
 428 
Subsequently, Gardenier et al. (2003) have designed a hollow silicon MN array with sloping 429 
side wall, which is shown in Figure 16b. The length of the needles varies between 150 and 350 430 
μm, with a base diameter of 250 μm (measured at the widest section) and a maximum hole 431 
width of 70 μm. The centre of the hole is positioned 40 μm from the tip of the needle. Davis et 432 
al. (2004) have used a hollow metal MN array (Figure 17) with a tip diameter of 75 μm, base 433 
diameter of 300 μm, wall thicknesses of 5 μm and height of 500 μm to measure the required 434 
force for the insertion of MNs into the tissue. They reported that a force ranging between 435 
approximately 0.1 – 3 N is sufficient to penetrate a single MN into the tissue.  436 
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 437 
Figure 17: Hollow metal MNs (Davis et al., 2004) 438 
Until now MNs have been developed as a minimally invasive means to deliver genes via the 439 
transdermal route (Tuan-Mahmood et al., 2013; Coulman et al., 2009; Henry et al., 1998), e.g., 440 
Chabrai et al. (2004) have successfully used micro-fabricated silicon MNs for non-viral gene 441 
delivery without causing pain. Recently, Zhang et al. (2013) have proposed the use MNs with a 442 
gene gun system to assist the micro-particle delivery in the skin. In particular, solid MNs can 443 
create holes in the tissue to provide an environment for the penetration of high-speed 444 
micro-particles. Furthermore, hollow MNs may allow a number of micro-particles to go through 445 
the hollow needles and penetrate to a greater depth into deeper tissue layers to be gene 446 
transfected. However, the waste of micro-particles is likely to be higher as the hollow MNs 447 
have blockage problems.  448 
 449 
There have been a number of studies which report on the effects of MNs types and 450 
configuration on drug delivery (Han and Das, 2013; Olatunji et al., 2012; Al-Qallaf and Das, 451 
2009a,b, 2008; Al-Qallaf et al., 2009a,b, 2007; Davidson et al., 2008). The current contribution 452 
will focus on the most relevant MNs types and configurations; reviews of other aspects related 453 
to the application of MN may be found elsewhere (Olatunji and Das, 2011, 2010). 454 
 455 
3.2 MN insertion in skin 456 
MNs can overcome a target surface to provide an advantageous condition for micro-particle 457 
delivery (Zhang et al., 2013). Human skin consists of two distinct macroscopic layers called the 458 
dermis and the epidermis (Marks et al., 2006; Parker, 1991; Phipps, 1988) which are shown in 459 
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Figure 18. The epidermis layer consists of the stratum corneum (SC), the stratum basale (or 460 
stratum germinativum), stratum sinosum, and the stratum granulosum (Gerard et al., 2011; 461 
Marks et al., 2006; Holbrook, 1994). The top layer of the skin is the SC which is the major 462 
barrier for entry of foreign substances. The thickness of the epidermis varies with gender, age, 463 
ethnicity and the regions of the body, but has an average thickness of between 20 and 100 μm 464 
(Matteucci et al., 2009; Schaefer and Redelmeier, 1996). The thickness of the stratum 465 
corneum also varies with the above conditions, but the average thickness is between 10 and 466 
20 μm (Mohammed et al., 2012; Holbrook et al., 1974). 467 
 468 
 469 
Figure 18: The structure of the skin (MacNeil, 2007) 470 
 471 
Normally, MN insertion is painless as it simply penetrates the skin surface without reaching the 472 
dermis layer, which contains the nerves ending. (Gupta et al., 2011a; Silpi et al., 2011; 473 
Donnelly et al., 2010a; Henry et al., 1998). Pain sensation depends on the MN design which is 474 
generally small enough to avoid significant damage to the nerves in the tissue (Shah et al., 475 
2011; Palastanga et al., 2006; Kaushik et al., 2001). Also, as the pain sensation is related to 476 
the MN design, an increased size increases the likelihood of stimulating the nerves (Sachdeva 477 
and Banga, 2011; Shah et al., 2011; Gupta et al., 2011a,b). There are a number of clinical 478 
studies which show that MNs insertions into skin are painless, or the pain is undetectable. For 479 
example, Mikolajewska et al. (2010) have used polymeric MN cones with needle height of 644 480 
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μm, base diameter of 217 μm tapering to tip diameter of 41 μm to progress the skin 481 
pre-treatment and report that the MNs insertion is a painless process. Previously, Haq et al. 482 
(2009) have used several MN arrays with lengths of 180 and 280 μm and compared the pain 483 
responses of a number of subjects for these MNs with the pain responses from hypodermic 484 
needles. They indicated that a hypodermic needle is painful after insertion into skin, and the 485 
pain response of MN insertion is less and decreases with a decrease in needle height. 486 
 487 
The irregular surfaces and viscoelasticity of skin causes difficulty with MN insertion. In 488 
addition, the skin is generally folded after the insertion of MNs, which may cause MNs to pierce 489 
partially, depending on the MN length (Verbaan et al., 2008). Thus, there is a need to 490 
understand the required force to insert a given MNs in the skin; the depth of MN penetration 491 
into the skin is directly related to the used force for penetration (Olatunji et al., 2013; Donnelly 492 
et al., 2010b). In addition, the depth of MN penetration in the skin is dependent on the length of 493 
MNs (Badran et al., 2009). 494 
 495 
Figure 19: Methylene blue staining of MN holes on the human skin (needle height: 180 and 496 
280 μm) (Haq et al., 2009) 497 
 498 
Several studies of MN insertion in skin show that the holes remain in the skin after the removal 499 
of the MNs (e.g., Haq et al., 2009), as shown in Figure 19. Previously, McAllister et al. (2003) 500 
have applied a cylindrical MN of 20 µm diameter to perform staining experiments, which 501 
indicates that a hole will remain after the removal of MNs. Martanto et al. (2004) have shown 502 
that a number of visible holes remained when MNs were applied with needle lengths of 1000 503 
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µm and width of 200 µm by 50 µm on a rat skin. In addition, McAllister et al. (2003) have 504 
reported a residual MN hole of radius 6 µm following insertion of MNs with radius of 10 µm, 505 
which means that the holes shrink to ~60 percent of the diameter of the MNs. While inserting 506 
the MNs, it can also be seen that the entire MN length cannot be inserted into the skin 507 
completely, and the depth of penentration of MN in skin is related to its length and the 508 
application force. These factors directly affect the size of pierced holes before and after the 509 
removal of MNs, Donnelly et al. (2010b) have used optical coherence tomography (OCT) to 510 
detect the effect of MN height and application force on the depth of penentration inside the 511 
porcine skin. As shown in Figure 20a, the penetration depth is increased significantly by an 512 
increase in MN height and application force. In addition, the application force presents a 513 
positive effect on the penetration depth of the MN inside skin, as shown in Figure 20b: the pore 514 
width is increased by an increase in needle height and application force, when the base width 515 
is kept constant. However, there is a clear gap left between the MN base plate and the skin 516 
surface. Donnelly et al. (2011) have further used OCT to obtain 3D views of MN embedded in 517 
the human skin. They reported that a MN with needle height of 600 µm and base diameter of 518 
300 µm penetrated approximately 460 µm into the human skin with a clear gap of 136 µm 519 
between the MN base plate and skin. They also indicated that the width of the pierced holes in 520 
the skin was about 265 µm in diameter. These reports demonstrate that MN assisted 521 
micro-particle delivery is expected to realize a greater penetration depth of micro-particles in 522 
the skin. 523 
 524 
4. Potential of MN assisted micro-particle delivery 525 
4.1 MN assisted micro-particle delivery 526 
As mentioned earlier, cell and tissue damages are particular problems for the biolistic gene 527 
transfection (Obrien et al., 2011; Uchida et al., 2009; Thomas et al., 2001; Sato et al., 2000; 528 
Yoshida et al., 1997). Reduction in the operation pressure and in the particle size can minimize 529 
the cell damage, but these also decrease the momentum of the micro-particles. This 530 
minimizes the penetration depth of the micro-particles in the tissue and may cause a failure of 531 
the DNA transfection.  532 
 533 
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 534 
Figure 20: (a): A 2D OCT image for the investigation of the effect of the MN height on the 535 
penetration depth inside the porcine skin (A: 280 µm; B: 350µm; C: 600µm; D: 900µm) 536 
(Donnelly et al., 2010b) (b): A 2D OCT image to analyse the effect of the application force on 537 
the penetration depth of MN inside the porcine skin (A: 4.4 N; B: 7.0 N; C: 11 N; D: 16.4 N) 538 
(Donnelly et al., 2010b) (c): A 3D OCT image showing MN insertion in the skin (needle height: 539 
600 µm; base width: 300 µm; spacing: 300 µm) (Donnelly et al., 2011). 540 
 541 
Based on a consideration of reducing the operating pressure, a new concept of combining 542 
MNs with gene guns for micro-particle delivery has been presented by Zhang et al (2013). As 543 
presented in Figure 21, the concept may be developed from the light and Helios gas gun 544 
systems. The operating process consists of particle acceleration, separation and deceleration 545 
stages. For the acceleration stage, a pellet of micro-particles is loaded onto the ground slide 546 
which is accelerated by pressurized gas. The pellet is then separated into individual 547 
micro-particles by impaction onto a mesh stopping screen in the separation stage. The 548 
separated micro-particles spray forward through a conical nozzle with a uniform velocity and 549 
distribution to breach the skin tissue to target the cells of interest. 550 
 551 
As shown by Zhang et al (2013), by using an array of MNs it is possible to overcome the effect 552 
of the skin on the particle penetration. One of the many advantages of this new concept is that 553 
the pressurized gas will be released from the vent holes (see Figure 21), which is likely to 554 
avoid the damage of the target from the impaction of pressurized gas on tissue. In addition, the 555 
use of the ground slide slows down the velocities of micro-particles to reduce the impact force 556 
on tissue to minimize the cell damage. As required, the velocity is controllable by changing the 557 
driving pressure of compressed gas, if higher micro-particle velocities are necessary. Even if 558 
the micro-particles cannot reach the desired penetration depth due to insufficient momentum, 559 
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the use of MNs allows a number of micro-particles to penetrate further to achieve the purpose 560 
of gene transfection in the desired depth of the tissue. However, the disadvantage of this 561 
concept is that a very high impact velocity of micro-particles is not easy to achieve, because 562 
the ground slide has significant mass.  563 
 564 
Figure 21: A possible structure of MNs assisted micro-particle delivery system 565 
 566 
The solid MN used by Zhang et al. (2013) aimed to create holes on the skin to allow a number 567 
of micro-particles penetrate through the pierced holes and increase the penetration depth. 568 
Zhang et al. (2013) also indicate that some agglomerated micro-particle may be present in the 569 
target; the size of the agglomerates is controllable and decreases with a decrease in mesh 570 
size and binder concentration. Results (see Figure 22) have shown that a number of 571 
micro-particles are able to penetrate through the pierced holes (created by the MNs) and 572 
reached a greater penetration depth inside the target, demonstrating the feasibility of MN 573 
assisted micro-particle delivery. In principle, the maximum penetration depth of micro-particles 574 
is affected by the particle size, density and operating pressure which determine the 575 
momentum of the micro-particles and hence the impact of the particles on the target. An 576 
increased length of the pierced holes enhances the particle penetration depth due to a 577 
decreased resistance when micro-particle travel in the hole. The length of the pierced holes 578 
depends on the height of MN.  579 
  580 
Valve 
Gas cylinder 
Pellet Ground slide 
Vent hole Stopping screen 
Stopping wall Microneedle Target 
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 581 
 582 
Figure 22: Optical microscope image of stainless steel micro-particle penetration into agarose 583 
gel (Zhang et al., 2013) 584 
 585 
4.2 Effects of physical approaches to drug delivery 586 
With the development of transdermal drug delivery, several physical technologies have been 587 
developed, particularly in needle free gene gun systems. In order to understand the 588 
advantages of MN assisted micro-particle delivery for the drug/gene delivery, a comparison 589 
with other physical cell targeting approaches is presented in this section. Figure 23 illustrates a 590 
schematic of four physical cell targeting approaches, which include diffusional delivery (Figure 591 
23a), solid MN assisted micro-particle delivery (Figure 23b), hollow MN assisted micro-particle 592 
delivery (Figure 23c) and needle free biolistic micro-particle injection (Figure 23d). The route of 593 
the diffusion delivery (Figure 23a) is that the molecules permeates through the aperture of the 594 
SC and diffuse into the target (Glenn et al., 2003). It is a method which operates without 595 
damage to the skin.  596 
 597 
Figure 23: A schematic cross-section of the skin: (a) the normally diffusion route (b)route of 598 
solid MN assisted micro-particle delivery (c) route of hollow MN assisted micro-particle delivery 599 
(d) route of normal micro-particle penetration using a gene gun system (Kendall, 2006) 600 
 601 
In recent years, needle-free biolistic micro-particle delivery (Figure 23d) provides a great 602 
improvement for transdermal gene delivery. The principle of this technique is that DNA is 603 
(d) 
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(c) 
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(b) 
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loaded onto micro-particles which are accelerated to a sufficient velocity to pierce the skin and 604 
travel to a certain depth to achieve the DNA transfection in the viable epidermis layer. It can be 605 
seen from Figure 23d that micro-particles penetrate to greater depth than diffusion delivery. In 606 
addition, biolistic micro-particle delivery is painless as the micro-particles settle within 607 
epidermis without reaching the nerves (Quinlan et al., 2001). There are some disadvantages 608 
for biolistic micro-particle delivery such as micro-particle penetration causes a significant cell 609 
death in the skin due to impaction (O’Brien and Lummis, 2011; Raju et al., 2006; Sato et al., 610 
2000). In addition, pressurized gas may damage the skin surface, if the pressure is over than 611 
200 psi (Belyantseva, 2009; Uchida et al., 2009; Yoshida et al., 1997).  612 
 613 
As mentioned earlier, the method of MN assisted micro-particle delivery requires use of a MN 614 
to overcome the skin surface to deliver micro-particles to a greater depth. The projected routes 615 
are presented in Figure 23b-c. In Figure 23b the penetration depths of micro-particles are 616 
greater than for needle-free biolistic micro-particle delivery, due to the pierced holes providing 617 
a low resistance path for micro-particle penetration. Figure 23c shows hollow MN assisted 618 
micro-particle delivery, which should allow particles to penetrate further in the skin via the 619 
hollow needles. However, the disadvantage of MN assisted micro-particle delivery is that the 620 
process may be painful if the micro-particles are deliver into dermis which have nerves ending 621 
in that layer.  622 
 623 
Overall, it is obvious that needle-free biolistic micro-particle injection present more efficiency 624 
than diffusion delivery. Ziegler (2008) has shown that acceptable DNA vaccination requires the 625 
coated micro-particle to penetrate the skin surface with around 20-100 μm penetration depth. It 626 
indicated that needle-free biolistic micro-particle injection achieves a more efficient 627 
pharmaceutical effect than diffusion delivery. Further, MN assisted micro-particle delivery may 628 
deliver micro-particles deeper than the needle-free gene gun system in the skin to allow 629 
deeper tissues to be transfected. This it has been demonstrated that MN assisted 630 
micro-particle delivery may achieve a further enhanced DNA transfection in the target. 631 
  632 
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4.3 Modelling micro-particle delivery in skin 633 
The process of micro-particle delivery is normally divided into two stages, which are the 634 
particle acceleration and penetration stages. In the modelling, the acceleration stage should 635 
be considered along with the driving source (gas pressure) which accelerates the 636 
micro-particle to a sufficient velocity to pierce the skin surface. The velocity varies with the 637 
gene gun system design, particle density and size. For the penetration stage, the effect of the 638 
skin is the major resistance to prevent the micro-particle delivery. Micro-particle delivery 639 
requires breaching of the SC and piercing into the epidermis layer (Yager et al., 2013; Soliman 640 
et al., 2011b; Liu, 2006; Quinlan et al., 2001; Bennett et al., 1999; Trainer and Alexander, 641 
1997). The impact velocity, particle size and density, target density and yield stress are the 642 
major variables affecting the penetration depth.  643 
 644 
Normally, the micro-particle acceleration stage involves gas and particle flow for gas gene gun 645 
systems, e.g., CST, PowderJect and Helios Gene gun. The flow is defined as symmetric and 646 
fully turbulent in the device (Liu, 2006; Soliman et al., 2011a). A model which has been widely 647 
adopted to model micro-particle flow is based on a balance of forces using Newton’s second 648 
law and Stokes’ law. For example, Liu (2006) has focused on simulating the velocity 649 
distribution in the converging (conical) section of a venturi system which is developed from a 650 
gene gun, namely, the PowderJect system (PowderJect Research Ltd., Oxford, UK) 651 
(Bellhouse et al., 1999, 2003, 2006). The particle velocity has been simulated based on a 652 
balance between the inertia of micro-particles and other resistance forces acting on the 653 
particles. Zhang et al. (2007) have used the MATrix LABoratory (MATLAB, The MathWorks 654 
Inc., Natick , USA) (Shampine et al., 1997) to simulate three different stages of the particle 655 
delivery in the gene gun, namely, acceleration, separation and deceleration stages. In their 656 
work, the particle velocity is analyzed on the basis of Newton’s second law in the acceleration 657 
stage; an energy conservation law is applied to describe the separation of micro-carriers into 658 
micro-particles in the separation stage, and Stokes’ law is applied to model the penetration of 659 
micro-particles in the deceleration stage into a viscous target. Soliman et al. (2011b) have 660 
used a commercial turbo-machinery flow simulator, namely, FINETM/Turbo (NUMECA 661 
International, Brussel, Belgium) to simulate the behaviour of gas and particle flow in a 662 
supersonic core jet in a gene gun. This work used Newton’s second law to mimic the particle 663 
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trajectories and determine the penetration depths of micro-particles in the skin. As discussed 664 
below, a number of studies have shown that the penetration depth depends on the momentum 665 
of micro-particles which again depend on the particle size, density and velocity. 666 
 667 
For the penetration stage, various studies have separated the resistance force on the 668 
micro-particle into a yield force (Fy), frictional resistive force (Ff) and resistive inertial force of 669 
the target material (Fi) (Soliman et al., 2011b; Liu, 2007; Mitchell et al., 2003; Kendall et al., 670 
2001; Dehn, 1987). The force balance equation is shown below: 671 
                         )FFF(
dt
dvm yfi ++−=                              (1) 672 
From this the stopping distance can be calculated as  673 
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Based on this force balance equation, the theoretical penetration depth (equation 2) is 675 
obtained and adopted for the modelling. This model has been widely adopted in several 676 
studies. For example, Soliman et al. (2011b) have modelled the delivery of golden particle of 677 
diameters 1.8 and 5 μm using 3 MPa pressure and have shown that penetration depths of 678 
95μm and 135μm can be achieved for particle of diameters 1.8 and 5 μm, respectively. 679 
Kendall et al. (2001) have analysed the golden particle penetration by using equation 2 for 680 
particle penetration in human and porcine skins. In addition, predictions from the theoretical 681 
model have been shown to agree well with the experimental results by Kendall et al. (2001). 682 
More recently, Soliman et al. (2011b) have also implemented equation 2 in a theoretical model 683 
which is implemented using FINE/Turbo code to calculate the penetration depth of gold 684 
micro-particle inside the skin. 685 
 686 
5. Conclusion 687 
The background of the gene gun system for micro-particle delivery is reviewed in this paper. A 688 
number of gene gun systems have been listed and the operating principles along with their 689 
advantages and disadvantages have been studied briefly. In addition, the recommended gas 690 
type, particle material and size for these type engineering systems are discussed. The range 691 
of particle velocities and applied operating pressures for several gene gun systems are 692 
described, which indicated that cell/tissue damage is a major problem for biolistic 693 
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micro-particle delivery, due to the impaction of pressurized gas and high-speed micro-particles 694 
on the target tissue. In addressing this point, a new concept is proposed of MN assisted 695 
micro-particle delivery, which combines a gene gun system with MN to enhance the 696 
penetration depth of micro-particles. This technique may reduce the cell damage from 697 
pressurized gas and reduce the impact velocity of micro-particle. In order to further understand 698 
the MN assisted micro-particle delivery, a number of MN designs have been discussed, paying 699 
attention to key characteristics that affect biolistic delivery.  700 
 701 
A number of researchers have studied the MN insertion in the skin which suggests that holes 702 
remained on the skin after the removal of MNs. These indirectly show the feasibility of the MN 703 
assisted micro-particle delivery to enhance the penetration depths of micro-particles inside the 704 
target. Based on the above research works, the detailed penetration route of MN assisted 705 
micro-particle delivery is also discussed and compared with other physical approaches on 706 
drug delivery. Finally, various models of micro-particle delivery for different gene gun systems 707 
are described to understand the theoretical principles of micro-particle penetration and which 708 
may be used for modelling of MN assisted micro-particle delivery. 709 
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